FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
173 | Lab-on-chip (LOC) as a tool for parkinson disease diagnosis: preliminary evaluation of neuronal cell culture on LOC Rosanna Mallamaci1, Rosangela Cardone1, Lorenzo Guerra1, Maria Noemi Sgobba1, Marilena Ardone1, Antonio Ancona2, Annalisa Volpe2a, Stefania Caragnano2, Salvatore Petralia3, Adriana Trapani4 | 1Department of Biosciences, Biotechnologies and Environment, University of Bari “Aldo Moro”, Bari, Italy; 2Physics Department, Università degli Studi di Bari & Politecnico di Bari, Italy; 3Department of Drug and Health Sciences, University of Catania, Italy; 4Department of Pharmacy-Drug Sciences, University of Bari “Aldo Moro”, Bari, Italy.
59 -
010 | Combining a gemcitabine-derived prodrug, GEM-C18, with nanoparticles to counteract acidic ph-dependent chemoresistance of pancreatic adenocarcinoma Francesca Fracasso, Marilena Ardone, Tiago Miguel Amaral Carvalho1|2, Barbara Rolando3, Silvia Arpicco3, Valeria Bincoletto3, Francesca Bianco4, Alessandra Fiorio Pla4, Daniela Isabel Abbrescia5, Ylenia Antonacci5, Chrysovalentinos Pousis5, Sharon Natasha Cox1, Flaviana Marzano5, Graziano Pesole1, Apollonia Tullo5, Stephan Joel Reshikn1, Rosa Angela Cardone1 | 1Dept of Biosciences, Biotechnology and Environment, University of Bari, ltaly; 2CICS-UBI-Health Sciences Research Center, Universidade da Beira Interior, Covilhã, Portugal; 3Dept. of Drug Science and Technology, University of Turin, ltaly; 4Dept of Life Sciences and Systems Biology, University of Turin, Italy 5Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies – IBIOM - CNR, Bari, Italy.
37 -
004 | Oncogenic role of circBFAR in pancreatic cancer progression and chemoresistance Marilena Ardone1, Doron Tolomeo1, Francesca Fracasso1, Tiago Miguel Amaral Carvalho3, Lucrezia Calamo1, Barbara Rolando2, Silvia Arpicco2, Valeria Bincoletto2, Stephan Joel Reshkin1, Clelia Tiziana Storlazzi1, Rosa Angela Cardone1 | 1Dept of Biosciences, Biotechnology and Environment, University of Bari “Aldo Moro”, Bari, Italy; 2Dept of Drug Science and Technology, University of Turin, ltaly; 3Molecular Mechanisms of Cancer Program, Centro de Investigación delCáncer, CSIC and Universidad de Salamanca, Spain.
27
1 - 3 of 3 items